oxidopamine has been researched along with Abnormality, Heart in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, AK | 2 |
| McLaughlin, R | 1 |
| Chan, A | 1 |
| Duffield, R | 2 |
2 other studies available for oxidopamine and Abnormality, Heart
| Article | Year |
|---|---|
6-Hydroxydopamine induced cardiac malformations and alterations of the autonomic nervous system in the developing chicken embryo.
Topics: Adrenergic Agents; Adrenergic Fibers; Animals; Autonomic Nervous System; Chick Embryo; Choline O-Ace | 1999 |
6-Hydroxydopamine-induced developmental cardiac alterations in morphology, calmodulin content, and K(2+)-mediated [Ca(2+)](i)Transient of chicken cardiomyocytes.
Topics: Abnormalities, Drug-Induced; Adenosine Triphosphatases; Animals; Autonomic Nervous System; Brain; Ca | 2000 |